Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine in Treatment-Refractory or Residual Schizophrenia
NCT01244828Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2011
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asenapine in schizophrenia, sponsored by Organon & Co.. Started Apr 2011; status: completed.
02
Drugs
asenapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01244828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244828.